Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Bayer expands financing group for Monsanto bid: source

Published 06/02/2016, 06:52 PM
© Reuters. The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal

(Reuters) - German drugs and crop chemicals group Bayer AG (DE:BAYGn), which has made a $62 billion bid for U.S. seeds company Monsanto Co (N:MON), has added more banks to its acquisition financing package, according to a person familiar with the matter.

HSBC Holdings Plc (L:HSBA), Goldman Sachs Group Inc (N:GS) and JPMorgan Chase & Co (N:JPM) have joined existing Bayer advisers Bank of America Corp (N:BAC) and Credit Suisse Group AG (S:CSGN) in the loan facility, the person said on Thursday after the German newspaper Handelsblatt first reported on the news.

The loan facility totals 60 billion euros ($67 billion), and can be expanded up to 75 billion euros, the source added.

Bayer made an unsolicited takeover offer for Monsanto in May, aiming to create the world's biggest agricultural supplier. Monsanto turned down the offer as "incomplete and financially inadequate," but said it was open to further talks. The two companies have since sat down to try to negotiate a deal.

The loan facility, with a maturity of up to a year, will have around a 0.5 percent interest rate for the first half, Handesblatt reported.

"As a matter of principle, we do not comment on any market rumors," Bayer spokesman Michael Preuss said on Thursday.

The banks either declined or were not immediately available for comment.

($1 = 0.8972 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.